Gain of function and loss of function mutations of the TSH receptor have be
en implicated in the pathogenesis of various thyroid diseases. Gain of func
tion mutations, when somatic, are the first cause of autonomous nodules; wh
en germline, they are responsible for hereditary non-autoimmune toxic thyro
id hyperplasia and for some cases of sporadic congenital hyperthyroidism. A
subset of mutations modifying the receptor selectivity have recently been
found to be involved in the pathogenesis of familia! gestational hyperthyro
idism. These mutations are of great interest for understanding the mechanis
m of receptor activation. Loss of function mutations of the TSH receptor ar
e responsible for different phenotypes ranging from asymptomatic resistance
to TSH to overt congenital hypothyroidism.